期刊文献+

自分泌运动因子受体基因及其干扰RNA表达载体的构建

Construction of expression vector of autocrine motility factor receptor and its interference RNA
下载PDF
导出
摘要 目的构建AMFR基因的表达载体和AMFRsiRNA表达载体,观察AMFRsiRNA对AMFR基因表达的影响。方法采用PCR技术扩增AMFR基因,并将其插入到带FLAG标签的真核表达载体上;利用RNAi技术,设计并合成了两条针对AMFR基因的siRNA,将其克隆到pSliencer 2.1-U6 neo表达载体上。将构建的AMFR基因表达载体和AMFRsiRNA表达载体共转染人胚肾细胞293T,通过Western blot实验了解AMFRsiRNA对AMFR基因表达的影响。结果通过双酶切和测序鉴定表明,构建的AMFR基因表达载体和AMFRsiRNA表达载体序列正确;通过West-ern blot实验证明,构建的AMFRsiRNA能有效抑制AMFR基因的表达。结论成功构建了AMFR基因表达载体和AMFRsiRNA表达载体,且表达的AMFRsiRNA能有效地抑制AMFR基因的表达。 Objective To construct the expression vector of AMFR gene and AMFR siRNA,and to investigate the effect of AMFR siRNA on the expression of AMFR gene.Methods AMFR gene was amplified by PCR technique and the product of PCR was inserted into the pcDNA3-FLAGC eukaryotic expression vector.Two AMFR siRNAs were developed by RNAi technique and the AMFR siRNAs were inserted into the pSliencer 2.1-U6 neo expression vector.Then human embryo kidney 293T cells were co-transfected with the AMFR siRNA expression vectors and FLAG-tagged AMFR expression vector.The effect of AMFR siRNAs on the expression of AMFR gene was identified by Western blot.Results The expression vectors of AMFR gene and AMFR siRNAs were constructed and confirmed by restriction enzyme digestion and DNA sequence analysis.Western blot showed that AMFR siRNAs could effectively inhibit the expression of AMFR gene.Conclusion The expression vectors of AMFR gene and AMFR siRNAs were successfully constructed,and the AMFR siRNAs effectively inhibited the expression of AMFR gene.
出处 《基础医学与临床》 CSCD 北大核心 2010年第8期868-872,共5页 Basic and Clinical Medicine
基金 国家重点基础研究发展规划(973)(No2004CB518907) 国家自然科学基金(No30772562) 国家高技术研究发展计划(863)(2008AA02Z423)
关键词 AMFR 表达载体 RNAI 转染 AMFR expression vector RNAi transfection
  • 相关文献

参考文献9

  • 1Wang Wei, Yang Lianyue, Yang Zhili, et al. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma[ J ]. Dig Dis Sci, 2007, 52 ( 3 ) :770- 775.
  • 2Lundstrom K. Prospects of treating neurological diseases by gene therapy[ J]. Curr Opin Investig Drug, 2007, 8 ( 1 ) : 34 - 40.
  • 3Jain KK. Commercial potential of RNAi [ J ]. Mol Biosyst, 2006, 2(11) :523 -526.
  • 4Chen B, Mariano J, Tsai YC, et al. The activity of a human endoplasmic reficulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2- binding site[J]. Proc Natl Acad Sci USA, 2006, 103(2) : 341 - 346.
  • 5Kojic LD, Joshi B, Lajoie P, et al. Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cells [ J ]. Biol Chem, 2007, 282(40) :29305 -29313.
  • 6Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[ J]. Proc Nail Acad Sci USA, 2002, 99 (9) :6047 - 6052.
  • 7Lee NS, Dohjima T, Bauer G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells [ J ]. Nat Biotechnol, 2002, 20 ( 5 ) : 500 - 505.
  • 8Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian ceils[ J]. Nat Biotechnol, 2002, 20(5) :497 -500.
  • 9Brummelkamp TR, Bemards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells[J]. Science, 2002, 296(5567): 550-553.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部